Skip to Content

Arcapta Prices, Coupons and Patient Assistance Programs

Arcapta (indacaterol) is a member of the adrenergic bronchodilators drug class and is commonly used for COPD - Maintenance.

Arcapta Prices

This Arcapta price guide is based on using the discount card which is accepted at most U.S. pharmacies. The cost for Arcapta inhalation capsule 75 mcg is around $278 for a supply of 30, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Arcapta is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Arcapta availability.

Inhalation Capsule

75 mcg Arcapta inhalation capsule
from $277.54 for 30 each
Quantity Per unit Price
30 (5 x 6 each) $9.25 $277.54

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee. Printable Discount Card

Print Now

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Arcapta Coupons and Rebates

Arcapta offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Patient Assistance Programs for Arcapta

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Sunovion Support Prescription Assistance Program (Arcapta, Seebri & Utibron Neohaler)

Elligibility requirements:

  1. Must have no prescription coverage
  2. At or below 300% of FPL
  3. FDA-approved diagnosis
  4. The patient must reside in the US, Puerto Rico or the USVI.

Applicable drugs:

  • Arcapta (indaceterol) Neohaler